EcoDrugPlus

High Mobility Group-T Protein

Ensembl ID : ENSSTUG00000035731
Gene Symbol: LOC115204602
2 Cross references
504 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSSTUG00000012382
Gene Symbol: LOC115153846
2 Cross references
505 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSSTUG00000003100
Gene Symbol: LOC115205853
3 Cross references
503 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSSTUG00000022953
Gene Symbol: LOC115162867
3 Cross references
503 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSSTUG00000008152
Gene Symbol: HRH1
3 Cross references
180 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSSTUG00000047184
Gene Symbol: HRH1
3 Cross references
180 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSSTUG00000019579
Gene Symbol: HRH2
3 Cross references
181 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSSTUG00000002207
Gene Symbol: HRH2A
1 Cross references
183 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSSTUG00000005460
Gene Symbol: HRH2A
1 Cross references
183 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSSTUG00000025839
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSSTUG00000035494
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSSTUG00000039924
Gene Symbol: HDAC2
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).